EGM
MRNA icon

Engineers Gate Manager’s Moderna MRNA Stock Holding History

Engineers Gate Manager’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$496K Sell
7,085
-76,374
-92% -$3.95M 0.01% 1518
2026
Q1 		$4.24M Buy
83,459
+55,044
+194% +$2.57M 0.05% 435
2025
Q4 		$838K Sell
28,415
-199,599
-88% -$5.42M 0.01% 1124
2025
Q3 		$5.89M Buy
228,014
+213,586
+1,480% +$5.96M 0.07% 348
2025
Q2 		$398K Sell
14,428
-37,683
-72% -$992K 0.01% 1582
2025
Q1 		$1.48M Buy
+52,111
New +$1.85M 0.02% 858
2024
Q4 		– Sell
-56,067
Closed -$3.75M – 2453
2024
Q3 		$3.75M Buy
56,067
+4,125
+8% +$379K 0.07% 366
2024
Q2 		$6.17M Buy
+51,942
New +$6.57M 0.14% 201
2022
Q4 		– Sell
-1,744
Closed -$206K – 1901
2022
Q3 		$206K Sell
1,744
-1,418
-45% -$215K 0.01% 1307
2022
Q2 		$452K Sell
3,162
-4,411
-58% -$630K 0.02% 1168
2022
Q1 		$1.3M Buy
7,573
+5,265
+228% +$886K 0.05% 507
2021
Q4 		$586K Buy
2,308
+507
+28% +$148K 0.03% 942
2021
Q3 		$693K Buy
+1,801
New +$664K 0.04% 692
2021
Q2 		– Sell
-50,820
Closed -$6.66M – 1868
2021
Q1 		$6.66M Buy
50,820
+15,892
+45% +$2.3M 0.33% 31
2020
Q4 		$3.65M Buy
+34,928
New +$3.53M 0.16% 150

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Engineers Gate Manager's MRNA Position: Q2 2026 in Review

Engineers Gate Manager reduced its Moderna (MRNA) stake by 92% in Q2 2026, selling an estimated $3.95M and leaving 7,085 shares worth $496K. The position accounts for 0.01% of the portfolio, ranked #1518.

Engineers Gate Manager first reported a position in MRNA in Q4 2020 and has held it in 15 quarters since. The position peaked at $6.66M in Q1 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Engineers Gate Manager held 7,085 shares of Moderna worth $496K as of Q2 2026.
  • Engineers Gate Manager sold 76,374 Moderna shares in Q2 2026, an estimated $3.95M.
  • Moderna made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1518 holding.
  • Engineers Gate Manager first reported a position in Moderna in Q4 2020 and has held it in 15 quarters since.
  • Engineers Gate Manager's Moderna position peaked at $6.66M in Q1 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.